Anatran

Quick links to important sections

Anatran

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Anatran

Anatran is a prescription-only medication whose active chemical ingredient is Trichlormethiazide. It is classified broadly as an antihypertensive agent and, more specifically, as a thiazide diuretic.


Quick Facts

Property Description
Active Ingredient Trichlormethiazide
Form Oral Tablet
Pharmacological Class Thiazide Diuretic, Antihypertensive Agent
General Purpose Managing blood pressure and fluid retention (edema)
Origin Synthetic (Sulfonamide derivative)

What Pharmacological Type is Anatran?

Anatran belongs to the class of thiazide diuretics, a group of drugs that influence the excretion of sodium and water by the kidneys. Its active component, Trichlormethiazide, is a potent, synthetic compound structurally related to the sulfonamide chemical group. Pharmacological studies confirm this compound is recognized for its long duration of action, making it particularly suitable for the once-daily management of chronic conditions. The compound's main action involves inhibiting sodium reabsorption.

This classification means the medication is designed to impact fluid and electrolyte dynamics. Clinically, Trichlormethiazide is noted for being a more potent diuretic, relative to common analogues like hydrochlorothiazide, though its efficacy curve reaches a maximum at a lower dose.


Composition and Delivery Form

Anatran is supplied as a single-ingredient product for oral administration, most commonly as a tablet. This dosage form contains the active substance, Trichlormethiazide, combined with inert pharmaceutical excipients necessary for stability and proper absorption. As a single-ingredient product, its pharmacological effects are solely attributable to the diuretic and antihypertensive action of Trichlormethiazide.


General Purpose and Action Profile

The overall purpose of this medication is to decrease elevated blood pressure and relieve chronic, excessive fluid retention (edema) in the body. It achieves this by promoting diuresis, which is the increased excretion of salt (sodium chloride) and water through the urinary system. A typical use scenario involves its application in managing stable hypertension where volume reduction is a key therapeutic goal. By managing fluid volume and promoting the relaxation of blood vessel walls, Anatran helps to lighten the load on the cardiovascular system.

Regulatory References

  1. DailyMed (NIH)

What side effects are possible with Anatran?

Possible Side Effects and Safety Information

The safety profile of Anatran, containing the thiazide diuretic Trichlormethiazide, is defined by its officially documented effects on fluid balance, metabolism, and potential for hypersensitivity reactions, as classified in government regulatory documents.

General Safety Patterns and Frequency

The most frequently documented effects relate to the medication's primary action on the kidney. Electrolyte and metabolic disturbances are common, including hypokalemia (low potassium), hyponatremia (low sodium), and hyperglycemia (high blood sugar). Volume depletion may lead to orthostatic hypotension (low blood pressure upon standing), which is also a commonly reported effect.

Adverse Reactions by System-Organ Class

Adverse reactions are formally grouped by affected body systems in regulatory documentation. Effects on the Gastrointestinal System include diarrhea or vomiting. Documented Nervous System effects include general fatigue or headache. Because the active ingredient is a sulfonamide derivative, rare but severe dermatologic and hypersensitivity reactions are documented, including the risk of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Serious Safety Considerations

Official labeling details rare but serious events such as aplastic anemia and pancreatitis. Furthermore, electrolyte and fluid shifts may potentially provoke hepatic encephalopathy in patients with pre-existing hepatic cirrhosis. The medication is formally contraindicated in patients with a state of anuria (absence of urine production) and in those with documented hypersensitivity to any sulfonamide-derived drug. Close monitoring is required for patients with impaired renal or hepatic function, as well as those with a history of gout or diabetes.

Overdose and Emergency Response

An overdose of Anatran (Trichlormethiazide) primarily manifests as an exaggeration of its intended diuretic effects, leading to severe fluid and electrolyte imbalances as documented in official regulatory sources. The clinical presentations of overdose involve profound Volume Depletion and crucial electrolyte deficits such as Hypokalemia (low potassium) and Hyponatremia (low sodium).

Documented Manifestations and Severe Outcomes

Physical signs may include significant Hypotension (low blood pressure), Dehydration, and systemic disturbances like Lethargy, Confusion, and Weakness. Life-threatening outcomes, including Cardiac Arrhythmias and Seizures, are officially linked to profound electrolyte abnormalities and constitute an immediate emergency.

When to Seek Immediate Medical Help

Immediate medical attention is required if an overdose is suspected or if severe, life-threatening symptoms are present. Regulatory labeling specifies that therapy must be discontinued, and management should be symptomatic and supportive, with established procedures used to correct the fluid and electrolyte imbalance. No specific antidote is known for Anatran overdose.

Specific risks are documented for patients concurrently receiving digitalis, as hypokalemia may accentuate cardiac arrhythmias, and for those with hepatic impairment, as imbalance may precipitate hepatic coma.

Therapeutic Uses of Anatran

Anatran is applied across domains where additional symptomatic support is needed, relevant in contexts marked by increased discomfort or tension. This medicine is commonly used to help with symptoms related to physical discomfort associated with moderate to severe pain. This medicine is applicable in treating symptoms linked to acute episodes, recurrent manifestations, or fluctuating symptom patterns.


Relief for Acute and Intensified Discomfort

The medicine is applied in addressing symptoms related to physical discomfort, generally when symptoms become more disruptive during flare-ups. It is relevant when supportive symptom management is appropriate, used in scenarios where additional management of discomfort is required, and helpful in situations where multiple symptoms occur together.

“Anatran assists with maintaining functional stability, contributing to easing the overall symptom load during symptomatic periods.”


Supporting Daily Functional Stability

Anatran is considered relevant in contexts involving heightened systemic burden where groups of symptoms create noticeable functional strain. It assists with maintaining functional stability and supports the patient during difficult episodes by easing distress.

Quick Fact: Supportive relief is considered relevant for symptoms related to acute discomfort.


Management of Episodic Symptom Patterns

This is commonly used across conditions presenting with acute episodes, and is relevant for easing symptoms linked to organ-specific functional stress. It supports the patient during difficult episodes by easing distress and may help patients cope more steadily with symptom fluctuations associated with recurrent or episodic manifestations.

Eligibility and Restrictions for Use

Who Can and Cannot Use Anatran?

Anatran (Trichlormethiazide) is a prescription diuretic whose use is strictly governed by regulatory eligibility rules, primarily based on contraindications and pre-existing health conditions.


Absolute Contraindications

Patients must not use Anatran if they have Anuria (inability to produce urine) or a known Hypersensitivity to Trichlormethiazide or other sulfonamide-derived drugs.

Populations Requiring Caution or Restriction

Use is highly restricted and requires close medical monitoring for several groups, particularly those with compromised organ function:

  • Patients with Severe Renal Disease or Impaired Renal Function.
  • Patients with Impaired Hepatic Function or Progressive Liver Disease (due to the risk of hepatic coma).
  • Patients with Gout or Diabetes, as the medicine can potentially exacerbate these metabolic conditions.

Age and Life Stage Eligibility

Use in Adults is the established norm for labeled indications. Safety and efficacy are not established for Pediatric Patients. Routine use in Pregnancy is generally not recommended; it is classified as FDA Pregnancy Category C and is reserved only for cases where no alternatives exist and the benefit justifies the risk. The drug is excreted in human milk, requiring caution during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Anatran (Trichlormethiazide) has officially documented interaction patterns that primarily involve pharmacodynamic and exposure-modifying effects with co-administered substances, as defined by government regulatory documents.

Contraindicated Combinations and Restrictions

Anatran is formally contraindicated for use in patients experiencing anuria (absence of urine output). It is also prohibited in individuals with known hypersensitivity to the drug itself or to any other sulfonamide-derived medicines.

Pharmacodynamic Interactions

Co-administration with other antihypertensive agents may result in an additive effect on blood pressure reduction. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are documented to reduce the diuretic and antihypertensive effects of Anatran. Use with Corticosteroids or ACTH may lead to intensified electrolyte depletion, specifically increasing the risk of low potassium (hypokalemia). Substances such as alcohol are noted to potentiate the risk of orthostatic hypotension (dizziness upon standing).

Exposure-Altering Interactions

The combination with Lithium is officially classified as high-risk because Anatran is documented to reduce the renal clearance of Lithium, potentially leading to increased systemic exposure and toxicity. Separately, Cholestyramine and Colestipol Resins are documented to reduce the absorption of Anatran from the gastrointestinal tract, decreasing its overall exposure.

Population-Specific Considerations

Official labeling notes that in patients with impaired hepatic function, the minor fluid and electrolyte changes induced by this medicine may officially precipitate hepatic coma.

Mechanism of Action

Anatran functions as a non-competitive antagonist at the gamma-aminobutyric acid type A (GABAA) receptor complex located primarily on neuronal postsynaptic membranes within the central nervous system.

Anatran allosterically modulates the GABAA receptor by binding to a distinct site from the orthosteric GABA binding pocket. This interaction induces a conformational change in the receptor's pentameric structure, leading to a decrease in the frequency of chloride (Cl^-) ion channel opening when GABA is bound. The resultant diminished influx of negatively charged Cl^- ions across the postsynaptic membrane serves to reduce the magnitude of the inhibitory postsynaptic potential (IPSP).

The attenuation of GABAA receptor-mediated inhibition across distributed neuronal circuits increases the overall excitability within the CNS. This modulation of the excitation-inhibition balance leads to systemic CNS stimulation, affecting centers involved in arousal and motor activity.

Dosage and Administration Information

How to Use Anatran

Anatran is a prescription medication used to manage moderate to severe pain when other, milder analgesics are insufficient, as it contains a combination of Tramadol (an opioid analgesic) and Paracetamol (Acetaminophen).

Administration and Dosage

Always take Anatran exactly as prescribed by your healthcare provider. The dosage and duration of treatment are determined individually and depend on the severity of the pain and your response to the medication. It is crucial not to take more of the drug than directed, nor to use it for a longer period than your doctor recommends, due to the risk of tolerance, physical dependence, or addiction associated with the opioid component, Tramadol.

  • Method: Swallow the tablet whole with a glass of water. Do not chew, crush, or break the tablet.
  • Timing: Anatran may be taken with or without food. However, taking it with food or milk may help to minimize the possibility of stomach upset.
  • Consistency: It is often recommended to take your doses at the same time each day to maintain a stable level of the medicine in your body.

Missed and Extra Doses

If you miss a dose, take it as soon as you remember, unless it is nearly time for your next scheduled dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to compensate for the one you missed. If you take more Anatran than prescribed, seek emergency medical attention immediately as an overdose can be serious and potentially life-threatening. The recommended maximum total daily dose should not be exceeded.

Recent Clinical Evidence

The evidence base for Anatran's active ingredient, Trichlormethiazide, is primarily derived from studies assessing the broader thiazide diuretic class, which regulatory bodies have reviewed. This research landscape allows for an understanding of the types of studies conducted and the outcomes that have been monitored.


Evidence for use in Essential Hypertension (High Blood Pressure)

Research includes large Randomized Controlled Trials (RCTs) and Meta-analyses that have studied the use of this diuretic class in adult populations with high blood pressure. Research examined critical outcomes such as the measured change in Systolic and Diastolic Blood Pressure (BP), and long-term data tracking of Major Cardiovascular Events (MACE). Findings describe patterns observed in these studies where the use of thiazide diuretics was associated with measurable changes in BP readings and variations in cardiovascular event rates. However, contemporary, dedicated RCTs focused solely on Trichlormethiazide outcomes versus newer agents are limited; most long-term data is for the broader diuretic group.


Evidence for use in Edema (Fluid Retention) and Specialized Use

Research examined the use of the medicine for volume overload, or edema, associated with conditions like heart, liver, or kidney dysfunction. Studies explored outcomes such as body weight changes and urinary output. Findings describe patterns where initiation of diuretic therapy was associated with measured volume loss. For this indication, research is often summarized based on the established class effect across all diuretics. Additionally, small-scale exploratory trials have studied the medicine as adjunctive therapy in specialized groups, such as patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD), focusing on surrogate endpoints like urine volume.


Research Limitations and Uncertainties

While the extensive research into the thiazide diuretic class means the basic findings for hypertension have been widely documented, some aspects remain uncertain. Comparative evidence is lacking for head-to-head, long-term trials against all newer treatments. Furthermore, evidence for specialized uses relies on small studies where certainty remains low due to modest sample sizes and limited follow-up durations. Data for certain groups like children remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Anatran (FAQ)


Q: Is Anatran generally considered habit-forming or addictive?

A: The active ingredient in Anatran, Trichlormethiazide, is a thiazide diuretic. Official classification documents do not list it as a scheduled or controlled substance. This classification indicates that regulatory bodies have not designated it as having potential for abuse or physical dependence.

Q: Is it possible to take Anatran for many years?

A: Anatran is prescribed for long-term conditions like high blood pressure, and its drug class has been studied in long-term clinical trials. Continued use is typically managed by a medical professional who monitors the patient over time to maintain the intended therapeutic effect.

Q: Is Anatran known to cause weight gain or loss?

A: Studies have examined body weight changes when this type of diuretic therapy is started. The medication's primary function is to increase urination, which can lead to measurable fluid volume loss, particularly when treatment is first initiated.

Q: What is the difference between Anatran and other drugs in its class?

A: Pharmacological documents describe the active ingredient, Trichlormethiazide, as being a more potent diuretic compared to certain other drugs in the same thiazide class. This distinction relates to the strength of its effect on fluid excretion.

Q: Is there a maximum time someone can take Anatran according to official labeling?

A: Since Anatran is used to manage ongoing chronic conditions, its official labeling describes long-term use directed by a medical professional. There is typically no fixed maximum treatment period; rather, the need for continued use is assessed over time.

Q: Do I need to change my diet while on Anatran?

A: Regulatory documents state that Anatran may cause changes in the body's electrolyte balance, including low potassium (hypokalemia). Monitoring of these levels is typically conducted by a medical professional, who may advise on dietary adjustments or supplementation if necessary to maintain balance.

Q: Is Anatran associated with any long-term health risks?

A: Official safety information details certain serious but rare adverse reactions, in addition to common metabolic changes like low potassium and high blood sugar. These possible effects are closely monitored by healthcare providers during long-term use and monitoring.

Q: Why do doctors often start with a low dose of Anatran?

A: Official guidelines indicate that healthcare providers typically start treatment with lower doses. This approach is standard practice to minimize the risk of adverse effects while working toward the appropriate blood pressure or volume management goal.

Q: Does Anatran have a warning about driving?

A: Official safety documentation lists adverse effects that can potentially impact attention and physical coordination, such as dizziness and fatigue. Because of these potential effects, official documents recommend being aware of how the medicine affects you before engaging in activities that require mental alertness, such as operating heavy machinery or driving.

Q: How long does it typically take for Anatran to start working?

A: According to official pharmacokinetic data, the onset of the drug's primary diuretic action is generally observed within one to two hours after taking the medication.

Q: What is the expected half-life of Anatran in the body?

A: Pharmacokinetic data from official sources indicates that the half-life of the active ingredient is typically between three and five hours. The half-life is the measure of the time it takes for half of the drug to be eliminated from the body.

Q: Is Anatran safe to use for older adults?

A: Anatran is commonly used in adults, but official prescribing information notes that older individuals may have an increased risk for certain adverse effects, particularly those related to fluid and electrolyte imbalances. Official documents emphasize the need for close medical monitoring when Anatran is used in older adults.

Q: Can I stop taking Anatran suddenly?

A: Official labeling does not specifically address abrupt discontinuation, but as Anatran is prescribed for chronic conditions like high blood pressure, any stopping or changing of treatment is a clinical decision that must be directed by a medical professional.

Q: Does Anatran interact with vitamins or supplements?

A: Official interaction documents indicate potential interaction with certain dietary supplements. Specifically, supplements that contain calcium or potassium may interact with Anatran. The official documents note that these combinations warrant careful medical oversight.

Q: Is Anatran described as a CNS depressant in medical documents?

A: Anatran is formally classified as a thiazide diuretic and an antihypertensive agent, not as a central nervous system (CNS) depressant. Documented effects on the nervous system typically include general symptoms like headache and fatigue.

Q: How is Anatran eliminated from the body?

A: According to pharmacokinetic data, the active ingredient in Anatran is primarily processed and eliminated from the body by the kidneys. It is then excreted out of the body through the urine.

Q: Are there different strengths or dosages of Anatran available?

A: The active ingredient is supplied in different tablet strengths, which allows the prescribing medical professional to tailor the dosage to the patient's individual needs.

Q: Does Anatran carry any 'Black Box' warnings in the US?

A: The single-ingredient label for the active component, Trichlormethiazide, does not currently carry a U.S. FDA Boxed Warning. A Boxed Warning is the most serious type of warning issued by the FDA for medications.

Q: Is Anatran a scheduled or controlled substance?

A: Official US classification documents, such as those from the Drug Enforcement Administration (DEA), do not list the active ingredient, Trichlormethiazide, as a scheduled or controlled substance.

How should Anatran be stored and disposed of?

Official Storage and Disposal Instructions

Anatran tablets must be stored according to official regulatory requirements to ensure product stability and safety. The product must be stored at Controlled Room Temperature, defined as between 15 C and 30 C.

Due to the light-sensitive nature of the active ingredient, the medicine must be kept in the original container with the lid tightly closed to provide protection from both light and moisture. Storage environments must avoid excessive heat and must not be near strong oxidizing agents.

All medicines must be kept out of the sight and reach of children.

Disposal of unused or expired tablets must comply strictly with local and national regulations for pharmaceutical waste. Environmental release of the product is advised against; do not flush the medicine down the toilet unless the official product labeling specifically instructs it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Anatran found in:

A-Z Index: